| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/23/1997 | EP0784479A1 Inhibition of human rotavirus infection |
| 07/23/1997 | CN1155281A Noval pyrimidine derivatives and prepn. processes thereof |
| 07/23/1997 | CN1155246A CCK antibodies used to improve feed efficiency |
| 07/23/1997 | CN1154842A Skin-penetrating absorption prepration |
| 07/22/1997 | US5650504 Nucleic acids encoding eck receptor ligands |
| 07/22/1997 | US5650296 Expression of hepatitis B S and preS2 proteins in Pichia pastoris |
| 07/17/1997 | WO1997025430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 07/17/1997 | WO1997025331A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | WO1997025328A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025317A1 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity |
| 07/17/1997 | WO1997025066A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 07/17/1997 | WO1997025065A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 07/17/1997 | WO1997025055A1 Nisin in combination with glycerol monolaurate active against helicobacter |
| 07/17/1997 | WO1997025048A1 Novel cycloalkyl substituted imidazoles |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025045A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025042A1 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
| 07/17/1997 | CA2242609A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | CA2242430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | CA2242327A1 Novel substituted imidazole compounds |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
| 07/17/1997 | CA2239254A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives, preparation thereof, intermediates thereof and drugs containing same |
| 07/16/1997 | EP0783884A1 Preventive and remedy for diarrhea |
| 07/16/1997 | EP0783579A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 07/16/1997 | EP0783504A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/16/1997 | EP0783503A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO 1,2-a]PYRAZINE DERIVATIVES |
| 07/16/1997 | EP0783499A1 Benzofuran derivatives as tachykinin antagonists |
| 07/16/1997 | EP0672056B1 Calcium channel blocking polypeptides from filistata hibernalis |
| 07/16/1997 | EP0601154B1 Bpc peptides, their preparation and use |
| 07/16/1997 | CN1154699A (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |
| 07/16/1997 | CN1154365A Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 07/16/1997 | CN1154254A Capsulized compound traditional Chinese proprietary medicine for treating cirrhosis of liver |
| 07/16/1997 | CN1154252A health-care medicinal liquor for treatinf diseases of digestive system and method for preparing same |
| 07/16/1997 | CN1154248A Traditional Chinese medicine |
| 07/15/1997 | US5648492 Process for preparing isoquinoline compounds |
| 07/15/1997 | US5648373 CoA-IT and PAF inhibitors |
| 07/15/1997 | US5648355 Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| 07/15/1997 | US5648092 Antiulcer |
| 07/15/1997 | US5647974 Hexagonal molecular structure water manufacturing apparatus and a method thereof |
| 07/10/1997 | WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024334A1 Benzimidazole derivatives |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024135A1 Amidino protease inhibitors |
| 07/10/1997 | WO1997024125A2 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | CA2240266A1 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/09/1997 | EP0783002A2 Dual action inhibitors |
| 07/09/1997 | EP0782446A1 Methods of inhibiting endometrial mitoses |
| 07/09/1997 | EP0782441A1 Pharmaceutical control of inflammation |
| 07/09/1997 | EP0720602B1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 07/09/1997 | CN1153662A Chinese medicine prepn for infant anorexia |
| 07/09/1997 | CN1153658A Medicine for nephropathy and gastropathy |
| 07/08/1997 | US5646303 Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein |
| 07/08/1997 | US5646289 Reacting a 3-chloro-1,2,5-thiadiazole with alkali metal bis(trialkyl or arylsilyl)amide; dechlorination; treating nervous system disorders |
| 07/08/1997 | US5646272 Bile acid conjugates of proline hydroxylase inhibitors |
| 07/08/1997 | US5646173 Tricyclic pyrrole derivatives useful as 5-HT selective agents |
| 07/08/1997 | US5646152 Treating psychological disorders with corticotropin releasing factor antagonists |
| 07/08/1997 | US5646144 For treating disorders in which substance p plays a part in development |
| 07/08/1997 | US5646118 Glutamine, fatty acid, insulin-like growth factors |
| 07/08/1997 | US5646117 Therapeutic agent for treating wounds using monocyte chemotactic and activating factor |
| 07/08/1997 | US5645983 Elisa, antibody-antigen complex |
| 07/08/1997 | US5645832 Use of lipases for producing drugs |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023485A1 Heteroarylcarboxamide derivatives |
| 07/03/1997 | WO1997023482A1 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives |
| 07/03/1997 | WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | WO1997023447A1 N-acylaminoalkylhydrazinecarboximidamides |
| 07/03/1997 | WO1997023199A1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/03/1997 | CA2241746A1 N-acylaminoalkylhydrazinecarboximidamides |
| 07/03/1997 | CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/02/1997 | EP0781558A2 Pharmaceutical use of heparin cofactor II |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781546A1 A multi-layered film preparation |
| 07/02/1997 | EP0781282A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/02/1997 | EP0781277A1 Neurokinin antagonists |
| 07/02/1997 | EP0781138A2 Lipid analogs for treating viral infections |
| 07/02/1997 | EP0781132A1 Methods of inhibiting ulcerative mucositis |
| 07/01/1997 | US5644050 Method for manufacturing lactulose anhydride |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643959 Method for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereof |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |
| 07/01/1997 | US5643930 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles |
| 07/01/1997 | US5643917 4-aminomethyl-1-azaadamantane derived benzamides |
| 07/01/1997 | US5643893 Antiinflammatory agents or antiarthritic agents |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |